(Q38202207)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Roberto Gnavi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

E Nada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

B Tartaglino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

L Marafetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

29 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, Obesity and Metabolism

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

1041-1047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702687%20AND%20SRC:MED&resulttype=core&format=json

Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds

13 March 2020

cites work

1 reference

Drug-induced pancreatitis: an update

21 January 2018

1 reference

Clinical practice. Acute pancreatitis

21 January 2018

1 reference

21 January 2018

1 reference

AGA Institute technical review on acute pancreatitis

21 January 2018

1 reference

Identification of a novel antibody associated with autoimmune pancreatitis

21 January 2018

1 reference

Drug-induced pancreatitis.

21 January 2018

1 reference

Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis.

21 January 2018

1 reference

Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes

21 January 2018

1 reference

Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study

21 January 2018

1 reference

Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study

21 January 2018

1 reference

Acute pancreatitis due to diabetes: the role of hyperglycaemia and insulin resistance.

21 January 2018

1 reference

Gallstone disease and related risk factors in a large cohort of diabetic patients

21 January 2018

1 reference

Phenformin-associated pancreatitis

21 January 2018

1 reference

Pancreatitis and phenformin.

21 January 2018

1 reference

Metformin and heart failure: innocent until proven guilty

21 January 2018

1 reference

Metformin induced acute pancreatitis precipitated by renal failure

21 January 2018

1 reference

Toxic metformin-associated acute pancreatitis without kidney failure

21 January 2018

1 reference

Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction

21 January 2018

1 reference

Acute pancreatitis in chronic kidney disease--a common but often misunderstood combination

21 January 2018

1 reference

Metformin treatment of diabetes mellitus increases the risk for pancreatitis in patients bearing the CFTR-mutation S573C.

21 January 2018

1 reference

Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis

21 January 2018

1 reference

New drugs for type 2 diabetes mellitus: what is their place in therapy?

21 January 2018

1 reference

Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor

21 January 2018

1 reference

Pioglitazone, a PPARgamma ligand, suppresses NFkappaB activation through inhibition of IkappaB kinase activation in cerulein-treated AR42J cells

21 January 2018

1 reference

Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury

21 January 2018

1 reference

Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice

21 January 2018

1 reference

Effects on digestive secretions

21 January 2018

1 reference

GLP-1 based agents and acute pancreatitis : drug safety falls victim to the three monkey paradigm

21 January 2018

1 reference

Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas

21 January 2018

1 reference

Pancreatitis: a potential complication of liraglutide?

21 January 2018

1 reference

Liraglutide-associated acute pancreatitis.

21 January 2018

1 reference

Acute pancreatitis associated with liraglutide.

21 January 2018

1 reference

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

21 January 2018

1 reference

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.

21 January 2018

1 reference

A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.

21 January 2018

1 reference

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study

21 January 2018

1 reference

Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis

21 January 2018

1 reference

A cohort study of acute pancreatitis in relation to exenatide use.

21 January 2018

1 reference

Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population

21 January 2018

1 reference

Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study

21 January 2018

1 reference

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study

21 January 2018

1 reference

A pooled analysis of exenatide use and risk of acute pancreatitis.

21 January 2018

1 reference

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

21 January 2018

1 reference